Consonance Capital Management LP Omeros Corp Transaction History

Consonance Capital Management LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$10.14 - $15.19 $4.91 Million - $7.35 Million	-484,042 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$9.57 - $21.32 $35.3 Million - $78.6 Million	-3,685,830 Reduced 88.39%	484,042 $4.89 Million
Q2 2020 Aug 14, 2020	SELL	$12.21 - $16.99 $3.79 Million - $5.27 Million	-310,000 Reduced 6.92%	4,169,872 $61.4 Million
Q1 2020 May 15, 2020	BUY	$9.03 - $19.72 $11.6 Million - $25.3 Million	1,284,076 Added 40.18%	4,479,872 $59.9 Million
Q4 2019 Feb 14, 2020	BUY	$13.01 - $17.15 $4.74 Million - $6.25 Million	364,687 Added 12.88%	3,195,796 $45 Million
Q3 2019 Nov 14, 2019	SELL	$14.55 - $20.56 $3.21 Million - $4.54 Million	-220,813 Reduced 7.24%	2,831,109 $46.2 Million
Q2 2019 Aug 14, 2019	BUY	$15.0 - $19.62 $13.9 Million - $18.2 Million	927,303 Added 43.65%	3,051,922 $47.9 Million
Q1 2019 May 15, 2019	BUY	$11.65 - $17.72 $24.8 Million - $37.6 Million	2,124,619 New	2,124,619 $36.9 Million

118

25.4M

317K

556K

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $263M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

Get notified when there are updates to the investment portfolio of Consonance Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Consonance Capital Management LP with notifications on news.